How does Venus collaborate with public health organizations to address critical health issues?
Venus Remedies actively collaborates with public health organizations to address critical health issues, particularly focusing on antimicrobial resistance (AMR) and advancing healthcare initiatives worldwide. Recently, Venus joined AMR Vivli, a global platform supported by the Wellcome Trust, dedicated to sharing AMR surveillance data. This membership enables Venus to contribute valuable data and insights to global efforts against AMR, reinforcing its commitment to combating this urgent health threat.
In addition, Venus partners with prominent global organizations such as UNICEF and PAHO, working together to address international health issues and improve healthcare access and outcomes globally. Venus also collaborates closely with the AMR Industry Alliance, promoting initiatives that advance AMR awareness, responsible antibiotic use, and stewardship practices on a large scale.
Further strengthening its impact in India, Venus has formed a notable partnership with Cipla. Together, they aim to tackle the overuse and misuse of antibiotics—primary drivers of AMR—and improve infection control practices across the country. Through this collaboration, they ensure that the groundbreaking antibiotic, Ceftriaxone Sulbactam EDTA (Elores), is widely accessible to patients nationwide.
Through these strategic partnerships, Venus Remedies combines expertise and resources from diverse organizations, driving critical healthcare advancements and addressing some of the most pressing public health issues.
Read more about us on our Social Media Handles and The Venus Times Newsletter.